Medisun Precision Medicine, Ltd. et al: Administrative Proceedings

Order Instituting Administrative Proceedings in the matter of Medisun Precision Medicine, Ltd., of the Marshall Islands, whose shares are listed on OTC Link; Next Graphite, Inc., of Nevada, and Omni Shrimp, Inc., of Nevada, before the U. S. Securities and Exchange Commission.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 4

Date: August 13, 2019

Defendant(s)/Respondent(s): Medisun Precision Medicine, Ltd., Next Graphite, Inc., Omni Shrimp, Inc.

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities, Regulatory

Plaintiff(s)/Applicant(s): Securities and Exchange Commission

Topics

Keywords

Medisun Precision Medicine, Ltd. Next Graphite, Inc. Omni Shrimp, Inc. Securities and Exchange Commission

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.